You are viewing: US Microbiology Testing Market analysis
Part of: Microbiology Testing Market (Global)

The US Microbiology Testing Market was valued at $730.2 Million in 2025 and projected to reach to $908.6 Million by 2030, representing a compound annual growth rate of 3.8%. The US microbiology testing market is positioned for sustained growth driven by increasing prevalence of infectious diseases, rising antibiotic resistance concerns, and growing demand for rapid diagnostic turnaround times in clinical settings.

US Microbiology Testing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Microbiology Testing Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, high diagnostic spending, and widespread adoption of automated microbiology platforms across clinical laboratories and hospitals.
  • Regulatory support from the FDA and increasing prevalence of infectious diseases drive demand for rapid and accurate microbiology testing solutions in the US. In the US, microbiology testing encompasses bacterial culture, fungal identification, antimicrobial susceptibility testing, and molecular diagnostics.
  • The US market is characterized by strong competition among established diagnostic companies and emerging technology providers.
  • Between 2025 and 2030, the US is expected to see accelerated adoption of next-generation sequencing and point-of-care testing, supported by reimbursement policies and clinical laboratory improvements.
  • The US continues to lead in innovation and standardization of microbiology testing protocols..

Key Market Statistics

  • CAGR (2025-2030) 3.8% CAGR
  • Market Size, 2025 ~USD 730.2 Million
  • Forecast, 2030 ~USD 908.6 Million
  • Country US

US Microbiology Testing Market Overview

Market Valuation :

The US microbiology testing market is valued at $730.2 million in 2025 and is projected to reach $908.6 million by 2030, representing steady growth in diagnostic capabilities.

Advanced Healthcare Infrastructure :

The US benefits from sophisticated laboratory networks, high diagnostic spending per capita, and widespread adoption of automated microbiology platforms across clinical laboratories and hospital systems.

Regulatory Support :

FDA regulatory framework and CLIA certification requirements drive standardization and quality assurance in US microbiology testing, supporting market expansion and innovation.

Growth Trajectory :

The US market is expanding at a CAGR of 3.8% through 2030, outpacing global growth rates and reflecting strong demand for rapid diagnostic solutions and antimicrobial susceptibility testing.

US Microbiology Testing Market Dynamics

  • Healthcare facilities are investing heavily in automated microbiology systems and molecular diagnostic platforms to improve patient outcomes and operational efficiency.
  • The market will benefit from technological advancements in next-generation sequencing and point-of-care testing solutions.
  • Regulatory support from the FDA and reimbursement policies continue to facilitate market expansion.
  • Additionally, the post-pandemic focus on infection prevention and control measures strengthens demand for comprehensive microbiology testing across hospitals, diagnostic laboratories, and specialty care centers throughout the United States..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US microbiology testing market is valued at $730.2 million in 2025 with projected growth to $908.6 million by 2030.
    • The US market grows at a 3.8% CAGR, driven by advanced healthcare infrastructure and FDA regulatory support.
    • Automation and molecular diagnostics are accelerating adoption across US clinical laboratories and hospitals.
    • The US leads in innovation with increasing adoption of next-generation sequencing and point-of-care testing solutions.

    Microbiology Testing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment VIRAL (Pathogen Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.3% from 2025 to 2030
    Largest Segment TRADITIONAL MICROBIOLOGY METHODS (TMM) (Technology Type)
    Market Size Base Year (Billions) ~USD 7.4 (2025)
    Revenue Forecast (Billions) ~USD 9.58 (2030)
    Segments Covered Product, Type, Technology Type, Pathogen Type, End User, Technology, End Users

    US Microbiology Testing Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments
    • Reagents & Kits

    By Type

    • Automated Culture Systems
    • Cellular Component-Based Rapid Microbiology Testing
    • Colony Counters
    • Culture Methods
    • Growth-Based Rapid Microbiology Testing
    • Incubators
    • Manual Counting Methods
    • Mass Spectrometers
    • Microscopes
    • Microscopy Methods
    • Nucleic Acid-Based Rapid Microbiology Testing
    • Other Instruments
    • Other Traditional Microbiology Methods
    • Staining Techniques
    • Viability-Based Rapid Microbiology Testing

    By Technology Type

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By Pathogen Type

    • Bacterial
    • Fungal
    • Other Pathogens
    • Viral

    By End User

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    By Technology

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By End Users

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    US: MICROBIOLOGY TESTING MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    COSMETICS & PERSONAL CARE COMPANIES152.7157.4162.3167.6173.4179.6186.4193.83.6
    ENVIRONMENTAL & WATER TESTING343.4358.6374.8392.4411.4432.1454.5478.95
    FOOD & BEVERAGE COMPANIES438.5454.1470.6488.5507.9528.9551.6576.34.1
    OTHER END USERS105.6108.4111.3114.5117.9121.7125.8130.23.2
    PHARMACEUTICAL & BIOTECH COMPANIES1433.81501.61573.71651.81736.51828.319282036.35.3
    TOTAL24742580.12692.72814.72947.13090.63246.43415.44.9

    Target Audience

    • Diagnostic Equipment Manufacturers : Manufacturers need US market intelligence to develop and position automated microbiology platforms, understand FDA approval pathways, and identify hospital procurement trends and competitive positioning.
    • Clinical Laboratory Operators : Laboratory managers require market data to benchmark operational performance, evaluate technology investments in automation, and understand reimbursement trends affecting profitability in the US market.
    • Healthcare System Administrators : Hospital and health system leaders need insights into microbiology testing demand, cost-benefit analysis of automation investments, and infection control implications for patient care quality.
    • In Vitro Diagnostics (IVD) Companies : IVD manufacturers need US-specific market data to guide product development, regulatory strategy, and commercial launch planning for microbiology testing reagents and assays.
    • Healthcare Investors & Consultants : Investment firms and management consultants require detailed US market analysis to evaluate acquisition targets, assess growth potential, and identify emerging opportunities in diagnostic testing sectors.

    Key Companies in the US Microbiology Testing Market

    CompanyHQOwnershipStrongest segments
    BIOMÉRIEUXFrancePublic CompanySyndromic and low-plex PCR (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE),Microbiology ID/AST and blood culture (VITEK 2, VITEK MS, VITEK REVEAL, BACT/ALERT, ETEST, API),Immunoassays and sepsis markers (VIDAS, Hybiome CLIA),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    MERCK KGAAGermanyPublic CompanyLife Science (lab and bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials),
    NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals,
    QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB and transplant/viral load assays),Oncology and sexual/reproductive health assays,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyLife Science instruments and systems,Life Science reagents and consumables,Clinical diagnostic test systems and informatics,
    BRUKERUnited StatesPublic CompanyNMR/EPR and Preclinical Imaging (BSI BioSpin),Mass Spectrometry, Molecular Diagnostics, and CALID Solutions,X-ray, AFM, and Nano-Analysis (BSI Nano),
    SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems,Industrial and Vacuum Machinery,
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    EUROFINS SCIENTIFICLuxembourgPublic CompanyFood and Feed Testing, Assurance and Certification,Environment Testing (water, air, soil, waste, maritime),Biopharma Services and Clinical Diagnostics,
    IDEXXUnited StatesPublic CompanyCompanion Animal Group (in-clinic analyzers, SNAP tests, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy plus Human Diagnostics,

    BIOMÉRIEUX

    bioMérieux is a French public company founded in 1963 that employs 14,894 people. The company operates in the life sciences and diagnostics sector.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a major player in the life sciences and laboratory services industry.

    MERCK KGAA

    Merck KGaA is a German public company with roots dating back to 1668 and currently employs 59,077 people. The company operates across pharmaceuticals, life sciences, and specialty chemicals.

    NEOGEN CORPORATION

    Neogen Corporation is a United States-based public company founded in 1981 with 2,974 employees. The company provides food and animal safety solutions.

    QIAGEN

    QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company specializes in molecular diagnostics and life sciences technologies.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.

    BRUKER

    Bruker is a United States-based public company founded in 1960 with 11,085 employees. The company develops scientific instruments and analytical solutions for research and diagnostics.

    SHIMADZU CORPORATION

    Shimadzu Corporation is a Japanese public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services for drug development.

    EUROFINS SCIENTIFIC

    Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.

    IDEXX

    IDEXX is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostics and software for veterinary and water testing markets.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation figures for the US market ($730.2M in 2025) with detailed forecasts through 2030, enabling accurate financial planning and investment decisions for stakeholders.
    • Competitive Landscape Analysis : Understand the US-specific competitive dynamics, key players in automated microbiology platforms, and market consolidation trends affecting laboratory service providers and diagnostic manufacturers.
    • Regulatory & Reimbursement Insights : Gain detailed knowledge of FDA regulations, CLIA requirements, and US reimbursement policies that directly impact market opportunities and pricing strategies for microbiology testing services.
    • Technology Adoption Trends : Identify adoption rates of molecular diagnostics, next-generation sequencing, and point-of-care testing solutions across US clinical laboratories, hospitals, and specialty diagnostic centers.
    • Strategic Growth Opportunities : Discover high-potential segments including antimicrobial resistance testing, rapid diagnostics, and automation solutions tailored to the US healthcare system's specific needs and infrastructure.

    Frequently asked questions

    What is the current size of the US microbiology testing market?

    The US microbiology testing market is valued at $730.2 million in 2025.

    What is the projected size of the US microbiology testing market by 2030?

    The US microbiology testing market is projected to reach $908.6 million by 2030.

    What is the growth rate of the US microbiology testing market?

    The US microbiology testing market is expected to grow at a compound annual growth rate of 3.8% from 2025 to 2030.

    What are the main drivers of growth in the US microbiology testing market?

    Key drivers in the US include advanced healthcare infrastructure, high diagnostic spending, FDA regulatory support, increasing infectious disease prevalence, and adoption of automated and molecular testing platforms.

    Which technologies are gaining traction in the US microbiology testing market?

    The US market is seeing accelerated adoption of next-generation sequencing, point-of-care testing, and automated microbiology platforms in clinical laboratories and hospitals.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics of the microbiology testing sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine segment and subsegment sizes.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    Microbiology Testing Market Size, and Share

    Note 1: Others include sales managers, marketing managers, and product managers.
    Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both the top-down and bottom-up approaches have been used to estimate and validate the size of the small satellite market.

    The top-down and bottom-up approaches were used to estimate and validate the total size of the microbiology testing market. These methods were also widely used to estimate the sizes of various market segments. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research.
    • The revenues generated by leading players operating in the microbiology testing industry have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Microbiology Testing Market : Top-Down and Bottom-Up Approach

    Microbiology Testing Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides.

    Market Definition

    Microbiology testing involves the identification, quantification, and analysis of microorganisms, including bacteria, viruses, fungi, and protozoa, and plays a critical role in ensuring product safety, protecting public health, and preserving environmental integrity. These tests are widely used across pharmaceutical and biotech companies, food and beverage companies, environmental and water testing, cosmetics and personal-care companies, the agriculture and animal feed industry, and academic and research institutes, where they support quality control, regulatory compliance, contamination monitoring, and scientific research activities.

    Key Stakeholders

    • Manufacturers & distributors of microbiology testing solutions
    • Food & beverage companies
    • Environmental and water testing organizations
    • Pharmaceutical & biotechnology companies
    • Cosmetics & personal care companies
    • Agriculture & animal feed industry
    • Contract testing laboratories
    • Academic & research institutes
    • Government and regulatory bodies
    • Market research & consulting firms
    • Venture capitalists & investors

    Report Objectives

    • To define, segment, and forecast the global microbiology testing market by product, technology, pathogen type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall microbiology testing market 
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the microbiology testing market using the company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Company Profiles

    • An additional five company profiles of players operating in microbiology testing.

    Regional Analysis

    • Further breakdown of the market segments at the country level

    Country Information

    • Additional country-level analysis of microbiology testing

     

    Get the Full Microbiology Testing Market Report

    Full forecast, segment splits, and company analysis for all Microbiology Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status